
The price history is unavailable right now.
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
Nothing in its numbers stands out right now.
No weak spot in its numbers right now.
Loading…
In 1 copy portfolio. See which with Premium
No company summary is available right now.
Clinical Trials Support Services - Global Strategic Business Report 2026: Capitalize on $15 Billion in New Revenue by 2032 as IQVIA, ICON, Labcorp, Parexel and Veeva Disrupt Trials with AIYahoo Finance · 1 d ago
Should Labcorp Stock Holders Look At Quest Diagnostics Instead?trefis.com · 4 d ago
Labcorp: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 5 d ago